Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
<p><strong>Background</strong></p> Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patien...
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Massachusetts Medical Society
2021
|